ASA Gold and Precious Metals (NYSE:ASA) and AIkido Pharma (NASDAQ:AIKI) Head-To-Head Comparison

ASA Gold and Precious Metals (NYSE:ASA) and AIkido Pharma (NASDAQ:AIKI) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations.

Analyst Recommendations

This is a summary of current ratings for ASA Gold and Precious Metals and AIkido Pharma, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASA Gold and Precious Metals	0	0	1	0	3.00
AIkido Pharma	0	0	0	0	0.00

Profitability

This table compares ASA Gold and Precious Metals and AIkido Pharma’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASA Gold and Precious Metals	N/A	N/A	N/A
AIkido Pharma	N/A	-18.21%	-16.94%

Insider and Institutional Ownership

10.9% of AIkido Pharma shares are held by institutional investors. 1.7% of ASA Gold and Precious Metals shares are held by company insiders. Comparatively, 8.6% of AIkido Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares ASA Gold and Precious Metals and AIkido Pharma”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASA Gold and Precious Metals	$732.36 million	1.33	N/A	N/A	N/A
AIkido Pharma	N/A	N/A	-$7.17 million	($3.88)	-0.66

ASA Gold and Precious Metals has higher revenue and earnings than AIkido Pharma.

Risk & Volatility

ASA Gold and Precious Metals has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

Summary

ASA Gold and Precious Metals beats AIkido Pharma on 5 of the 8 factors compared between the two stocks.

About ASA Gold and Precious Metals

ASA Gold and Precious Metals Limited is a publicly owned investment manager. The firm invests in the public equity markets across the globe. It primarily invests in stocks of companies engaged in the exploration, mining or processing of gold, silver, platinum, diamonds, or other precious minerals. It also invests in exchange traded funds. The firm employs fundamental analysis with a bottom-up approach to create its portfolios. The firm obtains external research to complement its in-house research. The firm is focused on covering the metals and mining sector. This record reflects the investment preferences or overall investment strategy of ASA Gold and Precious Metals Limited. ASA Gold and Precious Metals Limited was founded in 1958 and is based in Portland, Maine.

About AIkido Pharma

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.